A61P 9 - Drugs for disorders of the cardiovascular system

Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
11/2002
11/13/2002	CN1379764A Benzodiazepine derivatives
11/13/2002	CN1379763A Pyrazoloanthrone and derivatives thereof as JNK inhibitors and their compositions
11/13/2002	CN1379762A Beta substituted metalloprotease inhibitors
11/13/2002	CN1379761A Condensed indoline derivatives and their use as 5HT, in particular 5HT2C receptor ligands
11/13/2002	CN1379756A Substituted nor bornylamino derivatives, method for production thereof, use thereof as medicament or diagnostic reagent medicaments containing said compounds
11/13/2002	CN1379755A Substituted 2-dialkylamino alkylbiphenyl derivatives
11/13/2002	CN1379685A Novel method and composition for inhibition of angiogenesis using antagonists based on MMP-9 and beta integrins
11/13/2002	CN1379681A therapeutic angiogenic factors and methods for their use
11/13/2002	CN1379669A Valdecoxib compositions
11/13/2002	CN1379668A 3(5)-ureido-pyrazole derivatives, process for their preparation and their use as antitumor agents
11/13/2002	CN1379665A Method for delivering benzidine prostaglandins by inhalation
11/13/2002	CN1379047A Match of organic medicine and beta-cyclodextrin derivative and its preparing process
11/13/2002	CN1379042A Scorpion peptide for treating arrhythmia and its preparing process and application
11/13/2002	CN1379040A Soluble inorganic salt of Huanweihuangyangxing D, its preparing process and medicine containing it
11/13/2002	CN1378840A Slow-releasing composition of estrogen medicine and its preparing process
11/13/2002	CN1094126C Pyrroloazepine compounds
11/12/2002	US6479655 TNF receptor promoter
11/12/2002	US6479654 Forms of the angiogenic factor vascular endothelial cell growth factor: VEGF
11/12/2002	US6479630 Human purinergic P2U receptor
11/12/2002	US6479549 Alzheimer's disease; antiischemic agents
11/12/2002	US6479545 Formulation for menopausal women
11/12/2002	US6479541 Amiodarone-containing parenteral administration
11/12/2002	US6479540 Compositions of tocol-soluble therapeutics
11/12/2002	US6479534 Indoline derivatives and method of treating obesity
11/12/2002	US6479530 Substituted 4(5)-(1-indanyl,-indanylmethyl, indanylmethylen), 4(5)-(1-(1,2,3,4-tetrahydronaphthyl, -naphthylmethyl and naphthylmethylen)imidazoles; hypotensive, ischemic and anxiolytic agents; nervous and muscular system disorders
11/12/2002	US6479527 Bicyclic pyrrole derivatives as MCP-1 inhibitors
11/12/2002	US6479525 Aspartate derivative of amlodipine
11/12/2002	US6479513 Anticancer compound and enantiomer separation method useful for synthesizing said compound
11/12/2002	US6479512 Tyrosine kinase inhibitors
11/12/2002	US6479507 Modulation of these inflammatory cytokines is considered one of the most effective strategies to block chronic inflammation and have positive therapeutic outcomes
11/12/2002	US6479503 Cycloalkano-indole and -azaindole derivatives
11/12/2002	US6479502 Hydroxamic acid derivatives as proteinase inhibitors
11/12/2002	US6479497 Compounds having a selective effect at a subgroup of 5-hydroxytryptamine receptors, designated the h5-ht1b receptor
11/12/2002	US6479496 Treating a human patient suffering from variant and exercise-induced angina by administering a sustained release pharmaceutical dosage form including at least 50% by weight ranolazine in no more than two tablets per dose
11/12/2002	US6479492 Compounds which inhibit leukocyte adhesion mediated by VLA-4
11/12/2002	US6479490 Treatment of diseases characterized by excess th2 cytokines and/ or an excess ige production.
11/12/2002	US6479484 Substituted 2-aminoacetamides and the discovery that these compounds act as blockers of sodium channels; pain relievers, treatment of arrythmia, local anesthetics
11/12/2002	US6479483 3,4,6-substituted pyridine derivatives useful for treating depression and pain, resulting from inflammatory conditions, such as migraine, rheumatoid arthritis, asthma and inflamatory bowel disease; nk1 receptor antagonist
11/12/2002	US6479470 Naag and naaladase have been implicated in several pathological conditions relating to glutamate abnormalities and neurotoxicity
11/12/2002	US6479064 Culturing different cell populations on a decellularized natural biostructure for organ reconstruction
11/12/2002	CA2059558C Use of calcium antagonists for treating scars
11/12/2002	CA2055948C Use of a combination of angiotensin-converting enzyme inhibitor and calcium antagonist for the treatment of proteinuria
11/11/2002	CA2347879A1 Substituted dicinnamoylquinides and their use in augmentation of adenosine function
11/09/2002	CA2385412A1 Method of treating or inhibiting neutrophil chemotaxis by administering a mek inhibitor
11/07/2002	WO2002088664A2 Control of compactability through crystallization
11/07/2002	WO2002088366A1 Von willebrand factor (vwf)-cleaving enzyme
11/07/2002	WO2002088356A1 Novel g protein-coupled receptor protein and dna thereof
11/07/2002	WO2002088354A1 The nk1 fragment of hepatocyte growth factor/scatter factor (hgf/sf) and variants thereof, and their use
11/07/2002	WO2002088316A2 G-protein coupled receptors
11/07/2002	WO2002088182A1 Nove g protein-coupled receptor protein and dna thereof
11/07/2002	WO2002088159A1 Pharmaceutically active uridine esters
11/07/2002	WO2002088146A2 ANTIDEPRESSANT INDOLETETRAHYDROPYRIDINE DERIVATIVES OF 2,3-DIHYDRO-7H-[1,4]DIOXINO[2,3-e]INDOLE
11/07/2002	WO2002088138A1 Novel 4-amino-5,6-substituted thiopheno[2,3-d]pyrimidines
11/07/2002	WO2002088137A1 Pkb-3564 substance with neovascularization inhibitory activity
11/07/2002	WO2002088123A1 Chemical compounds
11/07/2002	WO2002088121A1 Pyrazolo[1,5-a]pyridines and medicines containing the same
11/07/2002	WO2002088118A1 Substituted benzofurans and benzothiophenes, methods of making and methods of use as integrin antagonists
11/07/2002	WO2002088115A1 Novel sulfonamide derivatives, intermediate thereof, its preparation methods, and pharmaceutical composition comprising the same
11/07/2002	WO2002088113A1 Triazole compounds useful in treating diseases associated with unwanted cytokine activity
11/07/2002	WO2002088110A1 Quinoline derivative having azolyl group and quinazoline derivative
11/07/2002	WO2002088109A1 Crystal of 6-[4-(4-pyridylamino)phenyl]-4, 5-dihydro-3(2h)-pyridazinone hydrochloride trihydrate
11/07/2002	WO2002088108A1 Triazole compounds useful in treating diseases associated with unwanted cytokine activity
11/07/2002	WO2002088100A2 Deuterated 3-piperidinopropiophenone and medicaments containing said compounds
11/07/2002	WO2002088097A1 Triazole-derived kinase inhibitors and uses thereof
11/07/2002	WO2002088095A1 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf)
11/07/2002	WO2002088094A1 2-iminoimidazole derivatives (1)
11/07/2002	WO2002088093A1 Benzimidazoles that are useful in treating sexual dysfunction
11/07/2002	WO2002088092A1 2-iminoimidazole derivative (2)
11/07/2002	WO2002088090A2 Pyrazole derived kinase inhibitors
11/07/2002	WO2002088089A1 Spiropiperidine derivatives, nociceptin receptor antagonists containing the same as the active ingredient and medicinal compositions
11/07/2002	WO2002088084A1 Heterocyclic compound derivatives and medicines
11/07/2002	WO2002088080A2 Dual inhibitors of pde 7 and pde 4
11/07/2002	WO2002088079A2 Dual inhibitors of pde 7 and pde 4
11/07/2002	WO2002088078A2 INHIBITORS OF GSK-3 AND CRYSTAL STRUCTURES OF GSK-3β PROTEIN AND PROTEIN COMPLEXES
11/07/2002	WO2002088073A1 Anthranilic acid amides, method for the production thereof, their use as antiarrhythmia agents, and pharmaceutical preparations thereof
11/07/2002	WO2002088071A1 20-hydroxyeicosatetraenoic acid production inhibitors
11/07/2002	WO2002087621A1 Pharmaceutical composition including ace/nep inhibitors and bioavailability enhancers
11/07/2002	WO2002087607A1 Use of agt and its derivatives for manufacturing anti-angiogenesis pharmaceutical compositions
11/07/2002	WO2002087605A2 Modified fvii in treatment of ards
11/07/2002	WO2002087604A2 Preparations containing a combination of vitamin e and afamin
11/07/2002	WO2002087601A1 Pharmaceutical composition containing bulbophyllum
11/07/2002	WO2002087593A1 A method for treating or preventing a functional vitamin b12 deficiency in an individual and to medical compositions for use in said method
11/07/2002	WO2002087584A1 Combinations of aldose reductase inhibitors and cyclooxygenase-2 inhibitors
11/07/2002	WO2002087583A2 Use of hiv-protease inhibitors to block cell migration and/or invasion, tissue infiltration and oedema formation
11/07/2002	WO2002087580A1 Abc expression promoters
11/07/2002	WO2002087569A1 Bisarylimidazolyl fatty acid amide hydrolase inhibitors
11/07/2002	WO2002087568A1 Utilization of anthranilic acid amides as a medicament for treating arrhythmias and pharmaceutical preparations that contain said compounds
11/07/2002	WO2002087559A1 Potassium channel opener
11/07/2002	WO2002087556A2 Probucol monoesters and their use to increase plasma hdl cholesterol levels and improve hdl functionality
11/07/2002	WO2002087548A1 A pharmaceutical tablet having a high api content
11/07/2002	WO2002087545A1 Composition and methods for treatment of hyperplasia
11/07/2002	WO2002087513A2 Fused heterocyclic inhibitors of phosphodiesterase (pde) 7
11/07/2002	WO2002087508A2 Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use
11/07/2002	WO2002087496A2 Methods for inhibiting macrophage colony stimulating factor and c-fms-dependent cell signaling
11/07/2002	WO2002087472A1 Stent-based delivery of statins to prevent restenosis
11/07/2002	WO2002087465A2 Compositions and methods of double-targeting virus infections and cancer cells
11/07/2002	WO2002087424A2 Treatment and diagnosis of macrophage mediated disease
11/07/2002	WO2002087419A2 Biological pacemaker
11/07/2002	WO2002074980A3 Muteins of hypoxia inducible factor alpha and methods of use thereof
11/07/2002	WO2002067955A3 A process for the manufacture of a herbal composition comprising a matrine

1 ... 1073 1074 1075 1076 1077 1078 1079 1080 1081 1082 1083 1084 1085 1086 1087 1088 1089 1090 1091 1092 1093 ... 1595